Loading...

China Pioneer Pharma Holdings Limited

1345.HKHKSE
Healthcare
Medical - Pharmaceuticals
HK$2.10
HK$-0.05(-2.33%)

China Pioneer Pharma Holdings Limited (1345.HK) Company Profile & Overview

Explore China Pioneer Pharma Holdings Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

China Pioneer Pharma Holdings Limited (1345.HK) Company Profile & Overview

China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOYuewen Yang

Contact Information

86 21 5049 8986
No.15, Lane 88 Wuwei Road, Shanghai, 200331

Company Facts

335 Employees
IPO DateNov 5, 2013
CountryCN
Actively Trading

Frequently Asked Questions

;